Drug Profile
Research programme: BBN-taxane therapeutics - Tapestry Pharmaceuticals
Alternative Names: BBN Taxane A proprietary Bombesin/paclitaxel conjugate; NBT-300Latest Information Update: 19 Nov 2007
Price :
$50
*
At a glance
- Originator Tapestry Pharmaceuticals
- Class Paclitaxels; Peptide hormones
- Mechanism of Action Microtubule protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 10 Aug 2005 Suspended - Preclinical for Cancer in USA (unspecified route)
- 04 May 2004 NaPro BioTherapeutics is now called Tapestry Pharmaceuticals
- 21 Nov 2003 Preclinical trials in Cancer in USA (unspecified route)